Long Non-Coding RNA OIP5-AS1 Contributes to Gallbladder Cancer Cell Invasion and Migration by miR-143-3p Suppression.
OIP5-AS1
gallbladder cancer
invasion
miR-143-3p
migration
proliferation
Journal
Cancer management and research
ISSN: 1179-1322
Titre abrégé: Cancer Manag Res
Pays: New Zealand
ID NLM: 101512700
Informations de publication
Date de publication:
2020
2020
Historique:
received:
25
08
2020
accepted:
26
11
2020
entrez:
28
12
2020
pubmed:
29
12
2020
medline:
29
12
2020
Statut:
epublish
Résumé
This study was designed to investigate the effect of long non-coding RNA (lncRNA) OIP5-AS1 on cell migration and invasion of gallbladder cancer (GBC) and its specific mechanism. The expressions of lncRNA OIP5-AS1 and OIP5-AS1 was highly expressed and LncRNA OIP5-AS1 accelerates the progression of GBC by suppressing miR-143-3p.
Identifiants
pubmed: 33364844
doi: 10.2147/CMAR.S278719
pii: 278719
pmc: PMC7751711
doi:
Types de publication
Journal Article
Langues
eng
Pagination
12983-12992Informations de copyright
© 2020 Li et al.
Déclaration de conflit d'intérêts
The authors declare they have no conflicts of interest.
Références
Biomed Pharmacother. 2018 May;101:14-23
pubmed: 29475118
Onco Targets Ther. 2019 Oct 01;12:8047-8053
pubmed: 31632058
Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8179-8185
pubmed: 30556856
Theranostics. 2018 Jan 1;8(4):1084-1105
pubmed: 29464001
Oncotarget. 2017 Jul 25;8(30):49409-49420
pubmed: 28472763
Am J Transl Res. 2018 Mar 15;10(3):866-874
pubmed: 29636876
J Cell Biochem. 2019 Jan;120(1):907-916
pubmed: 30188591
Thorac Cancer. 2018 Aug;9(8):939-949
pubmed: 29897167
Oncotarget. 2017 Apr 25;8(17):28711-28724
pubmed: 28404925
Surg Clin North Am. 2019 Apr;99(2):337-355
pubmed: 30846038
J Physiol Biochem. 2020 May;76(2):301-315
pubmed: 32157498
Front Cardiovasc Med. 2019 May 16;6:56
pubmed: 31157238
Onco Targets Ther. 2020 Mar 20;13:2357-2367
pubmed: 32256086
Biomed Pharmacother. 2018 Oct;106:1441-1447
pubmed: 30119217
Tumour Biol. 2016 Sep;37(9):12867-12875
pubmed: 27449039
Biosci Rep. 2020 Apr 30;40(4):
pubmed: 32270853
Front Pharmacol. 2019 Apr 24;10:449
pubmed: 31068824
Cell Death Dis. 2018 Feb 7;9(2):182
pubmed: 29416013
Oncotarget. 2017 Jul 18;8(29):47957-47968
pubmed: 28624787
Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):353-361
pubmed: 31899963
Biomed Pharmacother. 2019 Oct;118:109259
pubmed: 31369989
Cell Physiol Biochem. 2017;42(5):2078-2092
pubmed: 28803245
Mutat Res. 2018 Oct - Dec;778:61-71
pubmed: 30454684
Naunyn Schmiedebergs Arch Pharmacol. 2020 Nov;393(11):2177-2184
pubmed: 32009213
EMBO Rep. 2017 Oct;18(10):1837-1853
pubmed: 28887321
Mol Cancer. 2019 Nov 21;18(1):167
pubmed: 31752906
J Cell Physiol. 2019 Apr;234(4):5264-5275
pubmed: 30341904
J Gastrointest Cancer. 2014 Sep;45(3):245-55
pubmed: 24652122